Hence, we used the homeostasis model assessment of β-cell function (HOMA-β) and insulin resistance (HOMA-IR) to evaluate if the metabolic defects were the result of an altered β-cell functionality and/or insulin action (Suppl. This evidence concerns the gene INS and Insulin resistance.